Principal Investigator - Dr. Shahin Lockman MD, MPH
Study Objectives
Primary Objectives
Among HIV-infected and other child, adolescent, and adult HHCs of MDR-TB patients at high risk of developing TB:
PHOENIx (A5300B): Protecting Households on Exposure to Newly Diagnosed Index Multidrug Resistant TB patients
Network Studies
REPRIEVE (A5332): A randomized trial to prevent vascular events (such as stroke and heart attack) in people living with HIV.
Network Studies
Principal Investigator - Dr. Shahin Lockman MD, MPH
Study Objectives
Primary Clinical Objective
- To determine the effects of Pitavastatin as a primary prevention strategy for Major Adverse Cardiovascular Events (MACE) in HIV
Secondary Objectives
